title: [Effectiveness of the treatment of patients with fibrous-cavernous pulmonary tuberculosis].
abstract: The follow-up of 301 patients with fibrous-cavernous pulmonary tuberculosis has demonstrated that the disease outcome and treatment effectiveness depend on the nature of its course. A long-term specific therapy for 9-10 months brings about cessation of bacillary excretion in 50-60% of cases even in a progressive course of the disease and closure of destruction cavities occurred in 12.5% of cases with rapid progression and in 21.7% of cases with slow progression of the disease. Despite all measures taken, stabilization of the process fails in one-fourth of the patients with rapidly progressing fibrous-cavernous tuberculosis and in 9% of those with a slowly progressing course. In 90% of cases bacillary excretion in patients with stable fibrous-cavernous tuberculosis ceased in 3 months and in 100% after 6 months of treatment.
authors.forename: A S
authors.initials: AS
authors.lastname: Sadykov
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D011239:Prednisolone / Q000008:administration & dosage; D011658:Pulmonary Fibrosis / Q000150:complications / Q000382:microbiology / Q000628:therapy*; D012293:Rifampin / Q000008:administration & dosage; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000382:microbiology / Q000628:therapy*; D014945:Wound Healing / Q000187:drug effects
chemical_list: D004977:Ethambutol; D011239:Prednisolone; D012293:Rifampin
vernacular_title: Effektivnost' lecheniia bol'nykh fibrozno-kavernoznym tuberkulezom legkikh.